Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal International Journal of Health and Pharmaceutical (IJHP)
Sri Lestari Nasution
Program Study Master Of Public Health Faculty Of Medicine, Dentaland Health Science, University Prima Indonesia
Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Comparisonal Of Treatment Length And Laboratory Examination Comorbid And Non-Combid Disease On Covid 19 Patients At Hospital Royal Prima Nanda Terin Ibrena Sembiring; Tan Suyono; Sri Lestari Nasution
International Journal of Health and Pharmaceutical (IJHP) Vol. 2 No. 2 (2022): May 2022
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (304.336 KB) | DOI: 10.51601/ijhp.v2i2.48

Abstract

Covid-19 is an infectious disease caused by a new type of coronavirus with symptoms of acute respiratory distress such as fever, cough, and shortness of breath. The type of research is comparative research with secondary data collection of as many as 280 comorbid patients and 280 non-comorbid patients in the month of august 2021 – January 2022. Data were analyzed univariately, bivariate with test Mann Withney. The results of this study are: Based on the mean length of stay for comorbid patients was 12.22 higher than that of non-comorbid patients, which was 5.28. The results of the laboratory examination of leukocytes in comorbid patients were higher at 13.17 than in non-comorbid patients, namely 10.07. In contrast, platelets were smaller, namely 268.87 than non-comorbid patients, namely 278.91. Neutrophils in comorbid patients were 76.28 higher than non-comorbid patients, namely 61.13. The lymphocyte of comorbid patients was 13.28 smaller than that of non-comorbid patients, which was 25.93. The D-dimer of comorbid patients was not too much different, namely 1259.85 than that of non-comorbid patients, namely 557.16. The conclusion in this study is that there is a significant difference between length of stay and laboratory tests (leukocytes, platelets, neutrophils, lymphocytes, D-dimer) for comorbid and non-comorbid diseases in Covid-19 patients at Royal Prima Hospital Medan.
The Effect Of Risk Factors And Clinical Symptoms On Comorbid And Non-Comorbid Disease In Covid-19 Patients At Royal Prima General Hospital Medan Putri Gly De La Glory Ginting; Marlinang Isabela Silalahi; Sri Lestari Nasution
International Journal of Health and Pharmaceutical (IJHP) Vol. 2 No. 2 (2022): May 2022
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (392.75 KB) | DOI: 10.51601/ijhp.v2i2.52

Abstract

Covid-19 is a disease caused by infection with SARS-CoV-2 and causes a variety of clinical symptoms ranging from asymptomatic to critical symptoms, depending on various risk factors. The purpose of this research is to analyze the effect of risk factors (age, gender, occupation) and clinical symptoms (asymptomatic, mild, moderate, severe, critical) on comorbid and non-comorbid diseases in Covid-19 patients at General Hospital Royal Prima Medan. This Paper research used is quantitative research with secondary data collection in April-June 2021. The number of research samples was 308 comorbid patients and 308 non-comorbid patients. Data were analyzed univariately to see a descriptive picture, bivariate using chi-square test, and multivariate using binary logistic regression test. The results of this study are: based on age risk factors, the highest age group is 46-65 years (40.1%). The conclusions in this study are there is an influence of risk factors for age, gender, and mild, moderate, and severe clinical symptoms on comorbid and non-comorbid diseases in Covid-19 patients at Royal Prima Hospital Medan.
Co-Authors Marlinang Isabela Silalahi Nanda Terin Ibrena Sembiring Putri Gly De La Glory Ginting Tan Suyono